翰思艾泰(03378.HK)四项创新药将于AACR年会发表壁报研究成果

阿斯达克财经
Apr 12

翰思艾泰-B(03378.HK) 公布,公司四项创新药物(包括HX044、HX116、HX112及3D肿瘤类器官ADC评价体系)研究成果将于2026年美国癌症研究协会(AACR)年会以壁报形式展出。本次入选成果进一步验证公司的研发与创新能力。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10